OC-0599 Factors associated with SBRT doses in oligometastatic disease: an EORTC/ESTRO OligoCare analysis. (May 2022) - Guckenberger, M.; Alongi, F.; Ricardi, U.; Scorsetti, M.; Balermpas, P.; Livi, L.; Lievens, Y.; Braam, P.; Jereczek- Fossa, B.A.; Stellamans, K.; Ratosa, I.; Peulen, H.; et al.